WHO ICTRP trial

A pilot clinical trial assessing the efficacy and safety of supplementation with…

ACTRN12611000078954 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12611000078954
Public title A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy.
Scientific title A pilot clinical trial assessing the efficacy and safety of supplementation with a B complex vitamin to reduce the incidence of chemotherapy induced peripheral neuropathy in patients diagnosed with a malignancy.
Primary sponsor University of Queensland - Centre for Integrative Clinical and Molecular Medicine
Secondary sponsors University of Queensland - School of Medicine
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1
Countries Australia
Conditions Chemotherapy induced peripheral neuropathy; Chemotherapy induced peripheral neuropathy;Cancer - Other cancer types
Interventions Oral B group vitamin complex a) the dose administered is 1 capsule twice a day equivalent to 100mg of B1, 1000mcg of B12, 1000mcg of folinic acid, 60mg of B6, 1000mcg of biotin, 327mg of B5, 200mcg of inositol, 200mg of B3, and 40mg of B2…
Registration date Jan 21, 2011
Target size 135
Secondary IDs TGA trial number: 2010/0651;Protocol number: 2010000749
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations